Navigation Links
IDI-MRSA Test

ProductsIDI-MRSA Test
Company Cepheid
Item IDI-MRSA Test
Features 
  • Only FDA-cleared, rapid molecular test
  • Exclusively on the SmartCycler System
  • Highly sensitive test
  • Results in less than 2 hours
  • Detects from a single nasal swab specimen
  • Meets CDC guidelines for isolation precautions
  • Detection as low as 5 CFU per reaction
  • Eliminates false positives from methicillin-resistant CoNS (coagulase-negative staphylococci)
  • Available in 50-test and 200-test kits
  • Significantly reduces hands-on time
Description IDI-MRSA is the first diagnostic test cleared by the FDA and by Health Canada for the direct detection of nasal colonization by methicillin resistant Staphylococcus aureus (MRSA). Based on the real-time PCR technology, IDI-MRSA test results are available in about one hour after the collection of a nasal swab, compared to other methods that require two to five days. By detecting a single genetic sequence specific of MRSA, the IDI-MRSA assay provides a full response in a single step.

With its unique features, IDI-MRSA provides a key tool for the control and prevention of MRSA infections.

Info Cepheid
Customer Service: (408) 541-4191
Web site: http://www.cepheid.com/

Related medicine products :

1. 300XL Xenon Light Source
2. Xenon XL Light Source
3. Xenon Light Source
4. Xenon Light Source 175W With Turret
5. Xenon Surgical Headlight System
6. View Mex-2 Portable Xenon Headlight
7. View Mex-3 Portable Xenon Headlight
8. AL1 180W Xenon Light Source
9. 8430W 300 Watt Xenon Light Source
10. 175 watt Xenon Light Source
11. LS 7500 Xenon Light Source
Microscopic scissors, straight...
Microscopic needle holder, curved...
Velcro closures on each side to more evenly distribute the weight. Available in teal, royal, red, purple, or maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Fluoro done? Get rid of your apron quickly and easily without breaking the sterile field. A shoulder drop-away can also be used with our Stretchy-back and cummmberbund aprons. Shoulder pads and hangi...
Medicine Products:
(Date:4/1/2015)... (PRWEB) April 01, 2015 Taking an ... National League for Nursing Commission for Nursing Education ... has approved the first NLN CNEA Board of Commissioners. ... FAAN, ANEF, the 15-member board will provide leadership and ... overseeing all accreditation decisions for nursing programs that seek ...
(Date:4/1/2015)... April 01, 2015 BioPlus Specialty ... specialty pharmacies, has released a new app to keep ... for treating chronic hepatitis C virus (HCV) infection. This ... on information from the American Association for the Study ... , Numerous new direct-acting oral medications to treat HCV ...
(Date:4/1/2015)... 2015 SCI Solutions , the ... today announced that CEO Joel French will be a ... & Exhibition in Chicago, April 12-16, 2015. French ... Provider Care Coordination Strategies ” with Northeast Georgia Health ... CDT. More than 38,000 healthcare industry professionals are expected ...
(Date:4/1/2015)... Parents of teenaged and adolescent children might want ... post discusses Teen Violence Related to Substance Abuse. As ... Awareness Month, the substance abuse treatment center has issued ... identify if there may be problems with their kids ... alcohol. , “People learn how to establish healthy relationships ...
(Date:4/1/2015)... Tempaper has joined forces with the ... campaign that will raise critical funds to help save ... across the United States. , Throughout the month of ... will automatically receive free domestic ground shipping on ... needed progress to children and adults affected by muscular ...
Breaking Medicine News(10 mins):Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3
... -- Safety labels that outline concerns about medications, known ... drug categories, a new study suggests. These warnings ... single class of drugs, according to a team of ... also advised that supplemental warnings (for example, following a ...
... The National Heart, Lung and Blood Institute has ... of Louisville Health Sciences Center research scientist to form ... level. Dr. Roberto Bolli, director of the Institute ... Cardiovascular Medicine at UofL, is principal investigator of the ...
... by a team at the Peninsula College of Medicine ... there are benefits to mental and physical well-being from ... published in the leading research journal Environmental Science ... research team, supported by the NIHR Peninsula Collaboration in ...
... Society report says cancers associated with lifestyles and behaviors ... cancers, will continue to rise in developing countries if ... from the second edition of Global Cancer Facts & ... in CA: A Cancer Journal for Clinicians . ...
... , THURSDAY, Feb. 3 (HealthDay News) -- A single dose ... during the 2009 pandemic, a new study found. In ... as the AS03-adjuvanted pandemic H1N1 vaccine -- Canadian researchers looked ... four provinces between Nov. 8 and Dec. 5, 2009. ...
... Feb. 3 (HealthDay News) -- Minority patients suffering from ... greater chance of amputation than white patients, new research ... other potentially influential factors, such as patient income and ... to reflect upon the relatively lower socioeconomic status of ...
Cached Medicine News:Health News:'Black Box' Drug Warning Labels Applied Inconsistently: Study 2Health News:UofL awarded $9.56 million to form first-ever multicenter cardiovascular research network 2Health News:UofL awarded $9.56 million to form first-ever multicenter cardiovascular research network 3Health News:Review confirms benefits of outdoor exercise 2Health News:Review confirms benefits of outdoor exercise 3Health News:Report says economic development could change worldwide face of cancer 2Health News:Report says economic development could change worldwide face of cancer 3Health News:Report says economic development could change worldwide face of cancer 4Health News:Minorities With Severe Leg Blockages at Higher Risk of Amputation 2
(Date:4/1/2015)... NEW YORK , April 1, 2015  The ... ("ASPX" or the "Company") by Teva Pharmaceutical Industries ("Teva") ... action, shareholder rights law firm.  The investigation focuses on ... law by the Board of Directors of ASPX for ... 30, 2015, the Company announced a definitive agreement for ...
(Date:4/1/2015)... April 1, 2015 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral ... been enrolled in its Glucose Clamp Study. The study ... Science Center at San Antonio ... supervision of Professor Ralph DeFronzo . ...
(Date:4/1/2015)... KONG , April 1, 2015 Jintian ... code: 2211) announced that Mr. Jin Dongtao, chairman and ... the Company, representing 2% of the existing entire issued ... at HK$2.82 per share with the total amount of ... Mr. Jin Dongtao,s shareholding will increase from 45.17% to ...
Breaking Medicine Technology:WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5